Mechanisms and αpplications of ιnterleukins in cancer immunotherapy

D Anestakis, S Petanidis, S Kalyvas, CM Nday… - International journal of …, 2015 - mdpi.com
Over the past years, advances in cancer immunotherapy have resulted in innovative and
novel approaches in molecular cancer diagnostics and cancer therapeutic procedures …

Tumor-related interleukins: old validated targets for new anti-cancer drug development

S Setrerrahmane, H Xu - Molecular cancer, 2017 - Springer
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …

Interleukins in cancer: from biology to therapy

D Briukhovetska, J Dörr, S Endres, P Libby… - Nature Reviews …, 2021 - nature.com
Interleukins and associated cytokines serve as the means of communication for innate and
adaptive immune cells as well as non-immune cells and tissues. Thus, interleukins have a …

Molecular aspects and future perspectives of cytokine-based anti-cancer immunotherapy

DS Chulpanova, KV Kitaeva, AR Green… - Frontiers in cell and …, 2020 - frontiersin.org
Cytokine-based immunotherapy is a promising field in the cancer treatment, since cytokines,
as proteins of the immune system, are able to modulate the host immune response toward …

Cancer immunotherapy focusing on the role of interleukins; A comprehensive and updated study

M Samadi, A Kamrani, H Nasiri, N Shomali… - … -Research and Practice, 2023 - Elsevier
Cytokines bind to specific receptors on target cells to activate intracellular signaling
pathways that control diverse cellular functions, such as proliferation, differentiation …

Cytokine therapy in cancer

K Margolin - Expert opinion on biological therapy, 2008 - Taylor & Francis
Background: Cytokines provide important intercellular signals in inflammation, immunity and
tumor and endothelial cell biology. Several cytokines have therapeutic potential when …

Innate immunity in cancer biology and therapy

Y Zhang, W Xue, C Xu, Y Nan, S Mei, D Ju… - International Journal of …, 2023 - mdpi.com
Immunotherapies including adaptive immune checkpoint inhibitors (ICIs) and chimeric
antigen receptor (CAR) T cells, have developed the treatment of cancer in clinic, and most of …

Evolving strategies for tumor immunotherapy: enhancing the enhancer and suppressing the suppressor

Y Gu, Y Liu, X Cao - National Science Review, 2017 - academic.oup.com
Cancers develop complex and dynamic tissue microenvironments to support their sustained
growth, invasion and metastasis. For decades, rapid progress has been made in the cross …

The new progress in cancer immunotherapy

AS Shimu, H Wei, Q Li, X Zheng, B Li - Clinical and experimental medicine, 2023 - Springer
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …

Immuno-oncology-101: overview of major concepts and translational perspectives

B Allard, S Aspeslagh, S Garaud, FA Dupont… - Seminars in cancer …, 2018 - Elsevier
Cancer immunotherapy is demonstrating impressive clinical benefit in different malignancies
and clinical oncologists are increasingly turning their attention to immune-oncology. It is now …